Witteman G J, Brubaker S J, Johnson M, Marks R G
Ann Ophthalmol. 1985 Sep;17(9):525-6, 528-9.
A collaborative, retrospective study of 371 consecutive hyphema patients reveals an overall 3.5% incidence of rebleeding of without the use of antifibrinolytic agents. Numerous factors were reviewed on each patient, including age, sex, race, grade of hyphema, disposition, and the use of topical or systemic medications. Thirty percent of the patients were treated on an outpatient basis. The low incidence of rebleeding, particularly in less severe hyphemas (less than half the anterior chamber volume), does not support the routine use of systemic antifibrinolytics or corticosteroids.
一项针对371例连续性前房积血患者的回顾性合作研究显示,在未使用抗纤溶药物的情况下,再出血的总体发生率为3.5%。对每位患者的诸多因素进行了评估,包括年龄、性别、种族、前房积血分级、处置方式以及局部或全身用药情况。30%的患者接受门诊治疗。再出血发生率较低,尤其是在病情较轻的前房积血(前房容积小于一半)患者中,这并不支持常规使用全身抗纤溶药物或皮质类固醇。